April 7, 2023
Researchers Leverage Cell Self-Destruction to Treat Brain Tumors
Dominique Higgins, MD, PhD, led research into how a specialized diet can induce a new type of programmed cell death to help kill brain tumor cells.
Tag: UNC Lineberger Comprehensive Cancer Center
February 24, 2023
How a New Blood-Vessel-on-a-Chip Can Help Researchers Further Understand Vascular Malformations
A research team led by William Polacheck, PhD, at the UNC School of Medicine, has engineered a microfluidic model that mimics a rare genetic disorder affecting the structure of veins, arteries, capillaries, and lymphatic vessels.
February 20, 2023
Scientists Make Stunning Discovery, Find New Protein Activity in Telomeres
UNC School of Medicine researchers Jack Griffith, PhD, and Taghreed Al-Turki, PhD, found that telomeres at the tips of chromosomes contain sufficient genetic information to produce two small proteins with potentially potent biological properties.
February 6, 2023
Scientists Pinpoint Protein that Helps Cancer-Causing Viruses Evade Immune Response
Led by researchers in the UNC School of Medicine lab of Blossom Damania, PhD, a study in Nature Communications shows how Kaposi sarcoma-associated herpesvirus and Epstein-Barr virus hijack a human protein to help the viruses evade innate immune detection to spread undeterred.
January 9, 2023
Getting to the Heart of Chemotherapeutic Cardiotoxicity
Brian C. Jensen, associate professor of medicine and pharmacology in the Department of Medicine’s Division of Cardiology, speaks about his research on kinase inhibitor cardiotoxicity.
November 21, 2022
Ewend Leads UNC Hospitals Site for Successful National Glioblastoma Clinical Trial
A new glioblastoma treatment from Northwest Biotherapeutics improved outcomes for many patients in a phase 3 clinical study, according to a study published in JAMA Oncology. Matt Ewend, MD, in the UNC Department of Neurosurgery and at UNC Lineberger, led the trial site at the N.C. Basnight Cancer Hospital.
October 31, 2022
Damania Honored as AAAS Inductee
Vice Dean for Research Blossom Damania, PhD, was among the 2020 inductees to the American Academy of Arts and Sciences honored this fall in person after a two-year hiatus due to the COVID-19 pandemic.
July 21, 2022
UNC Lineberger Creates RNA Discovery Center
Chad Pecot, MD, associate professor of medicine and member of the UNC Lineberger Comprehensive Cancer Center, will lead the new center dedicated to the investigation of the many roles of RNA in health and disease.
April 12, 2022
Damania, Dittmer to be Honored in June with Battle Distinguished Cancer Research Awards
UNC Lineberger’s Blossom Damania, PhD, and Dirk Dittmer, PhD, are each 2021 recipients of the Hyman L. Battle Distinguished Cancer Research Award, and will be honored at a reception in June 2022 for their individual high impact research accomplishments that have advanced the field of tumor virology, their service to the UNC School of Medicine and university …
January 25, 2022
Donor Gives $25 million to Establish UNC Lineberger Center for Triple Negative Breast Cancer
The record-setting gift supports development of innovative cancer treatments, eradicating health disparities. The center's inaugural director is Lisa Carey, PhD, the Richardson and Marilyn Jacobs Preyer Distinguished Professor in Breast Cancer Research.
September 23, 2021
Therapy Using Dual Immune System Cells Effectively Controls Neuroblastoma
Hongwei Du, PhD, and Gianpietro Dotti, MD, published research in Nature Cancer showing that a dual-threat CAR-T immunotherapy was effective in animal models of neuroblastoma, a nerve cell cancer.
July 12, 2021
Carey Featured in Video on Clinical Implications of the FeDeriCa trial in HER2+ Breast Cancer
Lisa Carey, MD, member of the UNC Lineberger Comprehensive Cancer Center, discusses the clinical implications of the phase 3 FeDeriCa trial in HER2-positive breast cancer.